Dimensional Fund Advisors
XLRN

Dimensional Fund Advisors’s Acceleron Pharma XLRN Stock Holding History

Dimensional Fund Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-135,593
Closed -$23.3M – 3583
2021
Q3 		$23.3M Buy
135,593
+1,914
+1% +$250K 0.01% 1922
2021
Q2 		$16.8M Buy
133,679
+8,311
+7% +$1.05M 0.01% 2121
2021
Q1 		$17M Buy
125,368
+23,237
+23% +$3M 0.01% 2088
2020
Q4 		$13.1M Buy
102,131
+3,050
+3% +$358K ﹤0.01% 2177
2020
Q3 		$11.2M Sell
99,081
-81,484
-45% -$8.11M ﹤0.01% 2137
2020
Q2 		$17.2M Buy
180,565
+18,842
+12% +$1.82M 0.01% 1946
2020
Q1 		$14.5M Buy
161,723
+40,139
+33% +$3.12M 0.01% 1925
2019
Q4 		$6.45M Buy
121,584
+17,249
+17% +$786K ﹤0.01% 2523
2019
Q3 		$4.12M Buy
104,335
+62,315
+148% +$2.7M ﹤0.01% 2664
2019
Q2 		$1.73M Buy
+42,020
New +$1.74M ﹤0.01% 2937

Dimensional Fund Advisors's XLRN Position: Q4 2021 in Review

Dimensional Fund Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 135,593 shares — an estimated $23.3M sold.

Dimensional Fund Advisors first reported a position in XLRN in Q2 2019 and held it in 10 quarters. The position peaked at $23.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Dimensional Fund Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 135,593 Acceleron Pharma shares in Q4 2021, an estimated $23.3M.
  • Dimensional Fund Advisors first reported a position in Acceleron Pharma in Q2 2019 and held it in 10 quarters.
  • Dimensional Fund Advisors's Acceleron Pharma position peaked at $23.3M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Dimensional Fund Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.